Viewing Study NCT06830720

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-03-07 @ 1:03 PM
Study NCT ID: NCT06830720
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-interventional study View
None NIS View
None breast cancer View
None early breast cancer View
None HR+ View
None HER- View
None ribociclib View
None real world evidence View
None adjuvant therapy View